VCEL Stock Yearly Return 2024

This page is part of our 2024 average annual return archive: it shows the VCEL stock yearly return for calendar year 2024. This metric helps investors evaluate and compare performance among different stocks, over time.

Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2024 does not guarantee future similar returns.

Stock Yearly Return 2024
Start date: 01/03/2024
End date: 12/31/2024
Start price/share: $33.87
End price/share: $54.91
Dividends collected/share: $0.00
Total return: 62.12%
VCEL Average Annual Return: 62.46%
Starting investment: $10,000.00
Ending investment: $16,212.00
Years: 0.99


VCEL average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare VCEL average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into VCEL


Also see:
VCEL YTD return
VCEL average annual return 10 years
Vericel Corporation is a fully-integrated, commercial-stage biopharmaceutical company. Co. is a provider of advanced therapies for the sports medicine and severe burn care markets. It markets three products in the U.S.. MACI (autologous cultured chondrocytes on porcine collagen membrane) is an autologous-cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. The VCEL stock yearly return is shown above.

The yearly return on the VCEL stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2024 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the VCEL annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree VCEL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Vericel (VCEL) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

VCNX Average Annual Return
VCYT Average Annual Return
VERA Average Annual Return
VERO Average Annual Return
VERU Average Annual Return
VERV Average Annual Return
VIGL Average Annual Return
VINC Average Annual Return
VIR Average Annual Return
VIRX Average Annual Return
More Healthcare companies »

 

VCEL Stock Yearly Return 2024 | www.AverageAnnualReturn.com | Copyright © 2021 - 2025, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.